{
  "bio": [
    "Mori Arkin got his start in business in 1972 helping his father run a small Israeli pharmaceutical distribution company.",
    "The Arkins eventually moved into generic drug manufacturing, founding Agis Industries.",
    "In 2004, they sold Agis to U.S. pharmaceutical company Perrigo for $818 million in cash and stock.",
    "Still bullish on healthcare, he oversaw a January 2018 public offering on Nasdaq of Sol-Gel Technologies, a dermatology company. He owns over 65%."
  ],
  "about": [
    "His two sons are involved in the family business; his daughter is serving in the Israel Defense Forses.",
    "Arkin is an art history buff and enjoys composing music as a hobby."
  ]
}